CLIN TRANSL ALLERGY 润色咨询

Clinical and Translational Allergy

出版年份:暂无数据 年文章数:47 投稿命中率:暂无数据

出版周期:Irregular 自引率:10.5% 审稿周期:暂无数据

前往期刊查询

投稿信息

投稿信息
审稿速度
暂无数据 (网友贡献,非官方数据)
投稿命中率
暂无数据
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量6.38% (2018年为16.00%)
自引率
10.5 %
年文章数
47
期刊官网
点击查看 (点击次数:832)
点击查看 (点击次数:775次)
作者需知
点击查看 (点击次数:141次)
偏重的研究方向
暂无数据
期刊简介
稿件收录要求

Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience.

Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.

Beyond original research, Clinical and Translational Allergy also accepts structured reviews as well as opinion based reviews, and different position publications from EAACI or its National Societies.

Open access publishing enables free access to all content ensuring a wide dissemination of articles; the electronic format and expert peer review allows for very rapid publication. Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute.